CCCC
C4 Therapeutics Inc
3.00$
-6.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +278.3% | -73.5% | +0.0% | -1.3% | +8.6% | -5.0% | +34.9% | -25.2% | -7.0% | -5.6% | +688.9% | – | |
| – | -22.5% | -2.3% | +2.7% | +38.4% | -6.7% | -33.1% | -9.4% | -8.0% | -12.8% | -33.3% | +13.7% | – | |
| – | – | -1.4% | +74.8% | -253.4% | – | -286.2% | – | -321.2% | – | – | – | – | |
| – | -73.8% | -100.0% | – | -93.4% | -69.2% | -100.0% | – | +122.2% | -97.3% | +481.8% | -42.2% | – | |
| – | -44.7% | -267.1% | -78.1% | – | +8,338.3% | +113.1% | +33.6% | -89.5% | -2,075.8% | – | -191.7% | – | |
| – | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | -41.7% | +1,328.6% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -40.0% | -99.6% | +7,682.2% | -98.9% | -141.1% | -100.0% | – | +1,426.7% | -99.6% | +7,199.8% | – | |
| – | +303.4% | -156.3% | – | – | – | – | – | -172.0% | – | -184.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.